Simplex Trading
IPSC icon

Simplex Trading’s Century Therapeutics IPSC Stock Holding History

Simplex Trading’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$245 Sell
100
-1,800
-95% -$4.11K ﹤0.01% 9039
2026
Q1 		$4.29K Hold
1,900
– – ﹤0.01% 7986
2025
Q4 		$1.89K Buy
+1,900
New +$1.16K ﹤0.01% 7854

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Simplex Trading's IPSC Position: Q2 2026 in Review

Simplex Trading sold out of Century Therapeutics (IPSC) in Q2 2026, closing a stake of 9,028 shares — an estimated $20.6K sold.

Simplex Trading first reported a position in IPSC in Q2 2023 and held it in 6 quarters. The position peaked at $20.4K in Q1 2026. 99 funds tracked by Wall St. Rank hold IPSC as of Q2 2026.

  • Simplex Trading reported no remaining Century Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Simplex Trading sold 9,028 Century Therapeutics shares in Q2 2026, an estimated $20.6K.
  • Simplex Trading first reported a position in Century Therapeutics in Q2 2023 and held it in 6 quarters.
  • Simplex Trading's Century Therapeutics position peaked at $20.4K in Q1 2026.
  • 99 funds tracked by Wall St. Rank held Century Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.